Protalix (PLX) Enters ELELYSO Development Agreement w/ Pfizer (PFE)
Tweet Send to a Friend
Protalix BioTherapeutics, Inc. (AMEX: PLX) has entered into a Clinical Development Agreement with Pfizer Inc. (NYSE: PFE) under which Protalix ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
